Aspirin and prevention of preeclampsia;Aspirine et prévention de la prééclampsie

Revue de Medecine Interne

Volumn 21, Issue SUPPL. 1, 2000, Pages 68-74

  Beaufils, M ^a  

^a HÔPITAL TENON   (France)

Author keywords

Aspirin; Controlled trials; Preeclampsia; Prostaglandins

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; META ANALYSIS; MULTICENTER STUDY; NEWBORN; PREECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; TIME;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COHORT STUDIES; CONTROLLED CLINICAL TRIALS; CYCLOOXYGENASE INHIBITORS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFANT, NEWBORN; META-ANALYSIS; MULTICENTER STUDIES; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0347516600     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational-age infants. Br J Obstet Gynaecol 1986 ; 93 : 1049-59.
2. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998 ; 179 : 1359-75.
3. Roberts JM, Redman CWG. Preeclampsia: more than pregnancy-induced hypertension. Lancet 1993 ; 341 : 1447-51.
4. Smarason AK, Sargent IL, Starkey PM, Redman CW. The effect of placental syncytiotrophoblast microvillous membranes from normal and preeclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 1993 ; 100 : 943-9.
5. Redman CWG. Controlled trials of antihypertensive drugs in pregnancy. Am J Kidney Dis 1991 ; XVII : 149-53.
6. Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of preeclampsia by early antiplatelet therapy. Lancet 1985 ; 1 : 840-2.
7. Dekker GA, Sibai BM. Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms and clinical trials. Am J Obstet Gynecol 1993 ; 168 : 214-27.
8. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. New Engl J Med 1993 ; 329 : 1213-8.
9. Hauth JC, Goldenberg RL, Parker R, Philips JB, Copper RL, Dubard MB, et al. Low-dose aspirin to prevent preeclampsia. Am J Obstet Gynecol 1993 ; 168 : 1083-93.
10. Italian Study of Aspirin in Pregnancy. Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 1993 ; 341 : 396-400.
11. CLASP Collaborative group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994 ; 343 : 619-29.
12. ECPPA Collaborative group. ECPPA: randomized trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obstet Gynaecol 1996 ; 103 : 39-47.
13. Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in woment at high risk. New Engl J Med 1998 ; 338 : 701-5.
14. Bower SJ, Harrington KF, Schuchter K, McGirr C, Campbell S. Prediction of preeclampsia by abnormal uterine Doppler ultrasound and modification by aspirin. Br J Obstet Gynaecol 1996 ; 103 : 625-9.
15. Wang Y, Walsh SW, Romney A. Some doses of low-dose aspirin therapy may be too low to inhibit placental thromboxane and vasoconstriction [Abstract 210]. 10th World Congress of ISSHP. Seattle August 4-8 1996.
16. Hauth JC, Goldenberg EL, Parker CR Jr, Copper RL, Cutter GR. Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial. Am J Obstet Gynecol 1995 ; 173 : 578-84.
17. Hauth J, Sibai B, Caritis S, Vandordten P, Lindheimer M, Klebanoff M, et al. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. Am J Obstet Gynecol 1998 ; 179 : 1193-9.
18. Dumont A, Flahaut A, Beaufils M, Verdy E, Uzan S. Effect of aspirin in pregnant women is dependant on bleeding time increase. Am J Obstet Gynecol 1999 ; 180 : 135-40.
19. Leitich H, Egarter C, Husslein P, Kaider A, Schemper M. A metaanalysis of low-dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 1997 ; 104 : 450-9.